en.unionpedia.org

Semaglutide, the Glossary

Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management.^[1]

97 relations: Abdominal distension, Abdominal pain, Acetate, Addiction, Alanine, Alcoholic beverage, Amino acid, Anti-obesity medication, Arginine, Bariatric surgery, Beta cell, Binge eating, Binge eating disorder, Body mass index, Bowel obstruction, Boxed warning, Burping, Carboxylic acid, Committee for Medicinal Products for Human Use, Comorbidity, Constipation, Contraindication, Denmark, Diabetes management, Diarrhea, Dipeptidyl peptidase-4, Dizziness, Dulaglutide, Elevated transaminases, European Medicines Agency, Fatigue, Flatulence, Food and Drug Administration, Gastroenteritis, Gastroesophageal reflux disease, Gastroparesis, GLP-1 receptor agonist, Glucagon, Glucagon-like peptide-1, Gluconeogenesis, Glucose, Glycogenolysis, Grey market, Half-life, Headache, Health Canada, Heartburn, Hypoglycemia, Incretin, Indication (medicine), ... Expand index (47 more) »
2008 in Denmark
2008 in science
Danish inventions
Drugs developed by Novo Nordisk
Experimental drugs developed for non-alcoholic fatty liver disease
GLP-1 receptor agonists

Abdominal distension

Abdominal distension occurs when substances, such as air (gas) or fluid, accumulate in the abdomen causing its expansion.

See Semaglutide and Abdominal distension

Abdominal pain

Abdominal pain, also known as a stomach ache, is a symptom associated with both non-serious and serious medical issues.

See Semaglutide and Abdominal pain

Acetate

An acetate is a salt formed by the combination of acetic acid with a base (e.g. alkaline, earthy, metallic, nonmetallic or radical base).

See Semaglutide and Acetate

Addiction is a neuropsychological disorder characterized by a persistent and intense urge to use a drug or engage in a behavior that produces natural reward, despite substantial harm and other negative consequences.

See Semaglutide and Addiction

Alanine

Alanine (symbol Ala or A), or α-alanine, is an α-amino acid that is used in the biosynthesis of proteins.

See Semaglutide and Alanine

Alcoholic beverage

An alcoholic beverage (also called an adult beverage, alcoholic drink, strong drink, or simply a drink) is a beverage containing alcohol.

See Semaglutide and Alcoholic beverage

Amino acid

Amino acids are organic compounds that contain both amino and carboxylic acid functional groups.

See Semaglutide and Amino acid

Anti-obesity medication

Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat.

See Semaglutide and Anti-obesity medication

Arginine

Arginine is the amino acid with the formula (H2N)(HN)CN(H)(CH2)3CH(NH2)CO2H.

See Semaglutide and Arginine

Bariatric surgery

Bariatric surgery (or metabolic surgery or weight loss surgery) is a medical term for surgical procedures used to manage obesity and obesity-related conditions.

See Semaglutide and Bariatric surgery

Beta cell

Beta cells (β-cells) are specialized endocrine cells located within the pancreatic islets of Langerhans responsible for the production and release of insulin and amylin.

See Semaglutide and Beta cell

Binge eating

Binge eating is a pattern of disordered eating which consists of episodes of uncontrollable eating.

See Semaglutide and Binge eating

Binge eating disorder

Binge eating disorder (BED) is an eating disorder characterized by frequent and recurrent binge eating episodes with associated negative psychological and social problems, but without the compensatory behaviors common to bulimia nervosa, OSFED, or the binge-purge subtype of anorexia nervosa.

See Semaglutide and Binge eating disorder

Body mass index

Body mass index (BMI) is a value derived from the mass (weight) and height of a person.

See Semaglutide and Body mass index

Bowel obstruction

Bowel obstruction, also known as intestinal obstruction, is a mechanical or functional obstruction of the intestines which prevents the normal movement of the products of digestion.

See Semaglutide and Bowel obstruction

Boxed warning

In the United States, a boxed warning (sometimes "black box warning", colloquially) is a type of warning that appears near the beginning of the package insert for certain prescription drugs, so called because the U.S. Food and Drug Administration specifies that it is formatted with a 'box' or border around the text to emphasize it is of utmost importance.

See Semaglutide and Boxed warning

Burping

Burping (also called belching and eructation) is the release of gas from the upper digestive tract (esophagus and stomach) of animals through the mouth.

See Semaglutide and Burping

Carboxylic acid

In organic chemistry, a carboxylic acid is an organic acid that contains a carboxyl group attached to an R-group.

See Semaglutide and Carboxylic acid

Committee for Medicinal Products for Human Use

The Committee for Medicinal Products for Human Use (CHMP), formerly known as the Committee for Proprietary Medicinal Products (CPMP), is the European Medicines Agency's committee responsible for elaborating the agency's opinions on all issues regarding medicinal products for human use.

See Semaglutide and Committee for Medicinal Products for Human Use

Comorbidity

In medicine, comorbidity refers to the simultaneous presence of two or more medical conditions in a patient; often co-occurring (that is, concomitant or concurrent) with a primary condition.

See Semaglutide and Comorbidity

Constipation

Constipation is a bowel dysfunction that makes bowel movements infrequent or hard to pass.

See Semaglutide and Constipation

Contraindication

In medicine, a contraindication is a condition (a situation or factor) that serves as a reason not to take a certain medical treatment due to the harm that it would cause the patient.

See Semaglutide and Contraindication

Denmark

Denmark (Danmark) is a Nordic country in the south-central portion of Northern Europe.

See Semaglutide and Denmark

Diabetes management

The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentrations of a sugar called glucose in the blood.

See Semaglutide and Diabetes management

Diarrhea

Diarrhea (American English), also spelled diarrhoea or diarrhœa (British English), is the condition of having at least three loose, liquid, or watery bowel movements in a day.

See Semaglutide and Diarrhea

Dipeptidyl peptidase-4

Dipeptidyl peptidase-4 (DPP4 or DPPIV), also known as adenosine deaminase complexing protein 2 or CD26 (cluster of differentiation 26) is a protein that, in humans, is encoded by the DPP4 gene.

See Semaglutide and Dipeptidyl peptidase-4

Dizziness

Dizziness is an imprecise term that can refer to a sense of disorientation in space, vertigo, or lightheadedness.

See Semaglutide and Dizziness

Dulaglutide

Dulaglutide, sold under the brand name Trulicity among others, is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. Semaglutide and Dulaglutide are GLP-1 receptor agonists and peptide therapeutics.

See Semaglutide and Dulaglutide

Elevated transaminases

In medicine, the presence of elevated transaminases, commonly the transaminases alanine transaminase (ALT) and aspartate transaminase (AST), may be an indicator of liver dysfunction.

See Semaglutide and Elevated transaminases

European Medicines Agency

The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products.

See Semaglutide and European Medicines Agency

Fatigue

Fatigue describes a state of tiredness (which is not sleepiness), exhaustion or loss of energy.

See Semaglutide and Fatigue

Flatulence

Flatulence is the expulsion of gas from the intestines via the anus, commonly referred to as farting.

See Semaglutide and Flatulence

Food and Drug Administration

The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services.

See Semaglutide and Food and Drug Administration

Gastroenteritis

Gastroenteritis, also known as infectious diarrhea, is an inflammation of the gastrointestinal tract including the stomach and intestine.

See Semaglutide and Gastroenteritis

Gastroesophageal reflux disease

Gastroesophageal reflux disease (GERD) or gastro-oesophageal reflux disease (GORD) is a chronic upper gastrointestinal disease in which stomach content persistently and regularly flows up into the esophagus, resulting in symptoms and/or complications.

See Semaglutide and Gastroesophageal reflux disease

Gastroparesis

Gastroparesis (gastro- from Ancient Greek – gaster, "stomach"; and -paresis, πάρεσις – "partial paralysis"), also called delayed gastric emptying, is a medical disorder consisting of weak muscular contractions (peristalsis) of the stomach, resulting in food and liquid remaining in the stomach for a prolonged period of time.

See Semaglutide and Gastroparesis

GLP-1 receptor agonist

Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 analogs, GLP-1DAs or incretin mimetics, are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. Semaglutide and GLP-1 receptor agonist are GLP-1 receptor agonists.

See Semaglutide and GLP-1 receptor agonist

Glucagon

Glucagon is a peptide hormone, produced by alpha cells of the pancreas. Semaglutide and Glucagon are peptide hormones.

See Semaglutide and Glucagon

Glucagon-like peptide-1

Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone deriving from the tissue-specific posttranslational processing of the proglucagon peptide. Semaglutide and Glucagon-like peptide-1 are peptide hormones.

See Semaglutide and Glucagon-like peptide-1

Gluconeogenesis

Gluconeogenesis (GNG) is a metabolic pathway that results in the biosynthesis of glucose from certain non-carbohydrate carbon substrates.

See Semaglutide and Gluconeogenesis

Glucose

Glucose is a sugar with the molecular formula.

See Semaglutide and Glucose

Glycogenolysis

Glycogenolysis is the breakdown of glycogen (n) to glucose-1-phosphate and glycogen (n-1).

See Semaglutide and Glycogenolysis

Grey market

A grey market or dark market (sometimes confused with the similar term "parallel market") is the trade of a commodity through distribution channels that are not authorized by the original manufacturer or trade mark proprietor.

See Semaglutide and Grey market

Half-life

Half-life (symbol) is the time required for a quantity (of substance) to reduce to half of its initial value.

See Semaglutide and Half-life

Headache

Headache, also known as cephalalgia, is the symptom of pain in the face, head, or neck.

See Semaglutide and Headache

Health Canada

Health Canada (HC; Santé Canada, SC)Health Canada is the applied title under the Federal Identity Program; the legal title is Department of Health.

See Semaglutide and Health Canada

Heartburn

Heartburn, also known as pyrosis, cardialgia or acid indigestion, is a burning sensation in the central chest or upper central abdomen.

See Semaglutide and Heartburn

Hypoglycemia

Hypoglycemia, also called low blood sugar, is a fall in blood sugar to levels below normal, typically below 70 mg/dL (3.9 mmol/L).

See Semaglutide and Hypoglycemia

Incretin

Incretins are a group of metabolic hormones that stimulate a decrease in blood glucose levels. Semaglutide and Incretin are peptide hormones.

See Semaglutide and Incretin

Indication (medicine)

In medicine, an indication is a valid reason to use a certain test, medication, procedure, or surgery.

See Semaglutide and Indication (medicine)

Indigestion

Indigestion, also known as dyspepsia or upset stomach, is a condition of impaired digestion.

See Semaglutide and Indigestion

Insulin (medication)

As a medication, insulin is any pharmaceutical preparation of the protein hormone insulin that is used to treat high blood glucose.

See Semaglutide and Insulin (medication)

Liraglutide

Liraglutide, sold under the brand names Victoza and Saxenda among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. Semaglutide and Liraglutide are GLP-1 receptor agonists, peptide hormones and peptide therapeutics.

See Semaglutide and Liraglutide

Lotte Bjerre Knudsen

Lotte Bjerre Knudsen (born March 10, 1964) is a Danish scientist and university professor.

See Semaglutide and Lotte Bjerre Knudsen

Lysine

Lysine (symbol Lys or K) is an α-amino acid that is a precursor to many proteins.

See Semaglutide and Lysine

Marketing authorisation is the process of reviewing and assessing the evidence to support a medicinal product, such as a drug, in relation to its marketing, finalised by granting of a licence to be sold.

See Semaglutide and Marketing authorisation

Medication costs

Medication costs, also known as drug costs are a common health care cost for many people and health care systems.

See Semaglutide and Medication costs

Medicines and Healthcare products Regulatory Agency

The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.

See Semaglutide and Medicines and Healthcare products Regulatory Agency

Medullary thyroid cancer

Medullary thyroid cancer is a form of thyroid carcinoma which originates from the parafollicular cells (C cells), which produce the hormone calcitonin.

See Semaglutide and Medullary thyroid cancer

Metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is a type of chronic liver disease.

See Semaglutide and Metabolic dysfunction–associated steatotic liver disease

Multiple endocrine neoplasia type 2

Multiple endocrine neoplasia type 2 (also known as "Pheochromocytoma (codons 630 and 634) and amyloid producing medullary thyroid carcinoma", "PTC syndrome," and "Sipple syndrome") is a group of medical disorders associated with tumors of the endocrine system.

See Semaglutide and Multiple endocrine neoplasia type 2

National Health Service

The National Health Service (NHS) is the umbrella term for the publicly funded healthcare systems of the United Kingdom, comprising the NHS in England, NHS Scotland and NHS Wales.

See Semaglutide and National Health Service

National Institute for Health and Care Excellence

The National Institute for Health and Care Excellence (NICE) is an executive non-departmental public body, in England, of the Department of Health and Social Care, that publishes guidelines in four areas.

See Semaglutide and National Institute for Health and Care Excellence

Nausea

Nausea is a diffuse sensation of unease and discomfort, sometimes perceived as an urge to vomit.

See Semaglutide and Nausea

New Drug Application

The Food and Drug Administration's (FDA) New Drug Application (NDA) is the vehicle in the United States through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing.

See Semaglutide and New Drug Application

Nicotine

Nicotine is a naturally produced alkaloid in the nightshade family of plants (most predominantly in tobacco and Duboisia hopwoodii) and is widely used recreationally as a stimulant and anxiolytic.

See Semaglutide and Nicotine

Non-epileptic seizure

Non-epileptic seizures (NES), also known as non-epileptic events, are paroxysmal events that appear similar to an epileptic seizure but do not involve abnormal, rhythmic discharges of neurons in the brain.

See Semaglutide and Non-epileptic seizure

Novo Nordisk

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine countries and affiliates or offices in five countries.

See Semaglutide and Novo Nordisk

Novo Nordisk Foundation

The Novo Nordisk Foundation is an international enterprise foundation focusing on medical treatment and research.

See Semaglutide and Novo Nordisk Foundation

Obesity

Obesity is a medical condition, sometimes considered a disease, in which excess body fat has accumulated to such an extent that it can potentially have negative effects on health.

See Semaglutide and Obesity

Off-label use

Off-label use is the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

See Semaglutide and Off-label use

Oral administration

| name.

See Semaglutide and Oral administration

Pancreatitis

Pancreatitis is a condition characterized by inflammation of the pancreas.

See Semaglutide and Pancreatitis

PBS

The Public Broadcasting Service (PBS) is an American public broadcaster and non-commercial, free-to-air television network based in Crystal City, Virginia.

See Semaglutide and PBS

Peptic ulcer disease

Peptic ulcer disease is a break in the inner lining of the stomach, the first part of the small intestine, or sometimes the lower esophagus.

See Semaglutide and Peptic ulcer disease

Peptide

Peptides are short chains of amino acids linked by peptide bonds.

See Semaglutide and Peptide

Percentage point

A percentage point or percent point is the unit for the arithmetic difference between two percentages.

See Semaglutide and Percentage point

Phases of clinical research

The phases of clinical research are the stages in which scientists conduct experiments with a health intervention to obtain sufficient evidence for a process considered effective as a medical treatment.

See Semaglutide and Phases of clinical research

Proteolysis

Proteolysis is the breakdown of proteins into smaller polypeptides or amino acids.

See Semaglutide and Proteolysis

Reuters

Reuters is a news agency owned by Thomson Reuters.

See Semaglutide and Reuters

Rodent

Rodents (from Latin rodere, 'to gnaw') are mammals of the order Rodentia, which are characterized by a single pair of continuously growing incisors in each of the upper and lower jaws.

See Semaglutide and Rodent

Salt (chemistry)

In chemistry, a salt or ionic compound is a chemical compound consisting of an assembly of positively charged ions (cations) and negatively charged ions (anions), which results in a compound with no net electric charge (electrically neutral).

See Semaglutide and Salt (chemistry)

Self-harm

Self-harm is intentional conduct that is considered harmful to oneself.

See Semaglutide and Self-harm

Side chain

In organic chemistry and biochemistry, a side chain is a chemical group that is attached to a core part of the molecule called the "main chain" or backbone.

See Semaglutide and Side chain

Sodium

Sodium is a chemical element; it has symbol Na (from Neo-Latin natrium) and atomic number 11.

See Semaglutide and Sodium

Subcutaneous administration

Subcutaneous administration is the insertion of medications beneath the skin either by injection or infusion.

See Semaglutide and Subcutaneous administration

Suicidal ideation

Suicidal ideation, or suicidal thoughts, is the thought process of having ideas, or ruminations about the possibility of completing suicide.

See Semaglutide and Suicidal ideation

The Guardian

The Guardian is a British daily newspaper.

See Semaglutide and The Guardian

The New York Times

The New York Times (NYT) is an American daily newspaper based in New York City.

See Semaglutide and The New York Times

The Washington Post

The Washington Post, locally known as "the Post" and, informally, WaPo or WP, is an American daily newspaper published in Washington, D.C., the national capital.

See Semaglutide and The Washington Post

Therapy

A therapy or medical treatment is the attempted remediation of a health problem, usually following a medical diagnosis.

See Semaglutide and Therapy

Tirzepatide

Tirzepatide is an antidiabetic medication used for the treatment of typenbsp2 diabetes and for weight loss. Semaglutide and Tirzepatide are GLP-1 receptor agonists, peptide hormones and peptide therapeutics.

See Semaglutide and Tirzepatide

Vomiting

Vomiting (also known as emesis and throwing up) is the involuntary, forceful expulsion of the contents of one's stomach through the mouth and sometimes the nose.

See Semaglutide and Vomiting

Warren Alpert Foundation Prize

The Warren Alpert Foundation Prize is awarded annually to scientist(s) whose scientific achievements have led to the prevention, cure or treatment of human diseases or disorders, and/or whose research constitutes a seminal scientific finding that holds great promise of ultimately changing our understanding of or ability to treat disease.

See Semaglutide and Warren Alpert Foundation Prize

Weight loss

Weight loss, in the context of medicine, health, or physical fitness, refers to a reduction of the total body mass, by a mean loss of fluid, body fat (adipose tissue), or lean mass (namely bone mineral deposits, muscle, tendon, and other connective tissue).

See Semaglutide and Weight loss

Weight management

Weight management refers to behaviors, techniques, and physiological processes that contribute to a person's ability to attain and maintain a healthy weight.

See Semaglutide and Weight management

2-Aminoisobutyric acid

2-Aminoisobutyric acid (also known as α-aminoisobutyric acid, AIB, α-methylalanine, or 2-methylalanine) is the non-proteinogenic amino acid with the structural formula H2N-C(CH3)2-COOH.

See Semaglutide and 2-Aminoisobutyric acid

References

[1] https://en.wikipedia.org/wiki/Semaglutide

Also known as C187H291N45O59, O O O Ozempic, Oh Oh Oh Ozempic, Ozempic, Rybelsus, Semiglutide, Wegovy, Wegovy™.

, Indigestion, Insulin (medication), Liraglutide, Lotte Bjerre Knudsen, Lysine, Marketing authorisation, Medication costs, Medicines and Healthcare products Regulatory Agency, Medullary thyroid cancer, Metabolic dysfunction–associated steatotic liver disease, Multiple endocrine neoplasia type 2, National Health Service, National Institute for Health and Care Excellence, Nausea, New Drug Application, Nicotine, Non-epileptic seizure, Novo Nordisk, Novo Nordisk Foundation, Obesity, Off-label use, Oral administration, Pancreatitis, PBS, Peptic ulcer disease, Peptide, Percentage point, Phases of clinical research, Proteolysis, Reuters, Rodent, Salt (chemistry), Self-harm, Side chain, Sodium, Subcutaneous administration, Suicidal ideation, The Guardian, The New York Times, The Washington Post, Therapy, Tirzepatide, Vomiting, Warren Alpert Foundation Prize, Weight loss, Weight management, 2-Aminoisobutyric acid.

Semaglutide, the Glossary

Table of Contents

See also

2008 in Denmark

2008 in science

Danish inventions

Drugs developed by Novo Nordisk

Experimental drugs developed for non-alcoholic fatty liver disease

GLP-1 receptor agonists

References